ResMed Inc. (LON:0KW4)
London · Delayed Price · Currency is GBP · Price in USD 252.13
-4.44 (-1.73%)
Jan 30, 2026, 5:14 PM GMT
ResMed Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 1,486 | 1,401 | 1,021 | 897.56 | 779.44 | 474.51 |
Depreciation & Amortization | 220.8 | 210.34 | 188.76 | 172.51 | 158.3 | 146.19 |
Other Amortization | 25.4 | 25.47 | 27.45 | 25.06 | 35.55 | 40.23 |
Asset Writedown & Restructuring Costs | - | - | 33.24 | 9.18 | - | 13.77 |
Loss (Gain) From Sale of Investments | 14.06 | 10.3 | 4.05 | -9.92 | 12.2 | -14.52 |
Loss (Gain) on Equity Investments | -4.61 | -3.64 | 1.85 | 10.14 | 8.49 | 11.21 |
Stock-Based Compensation | 98.97 | 91.66 | 80.18 | 71.14 | 65.26 | 63.93 |
Other Operating Activities | - | - | - | -20.23 | - | - |
Change in Accounts Receivable | -87.96 | -76.68 | -134.28 | -106.51 | 19.35 | -129.2 |
Change in Inventory | 9.2 | -80.17 | 172.2 | -248.83 | -311.68 | -21.95 |
Change in Accounts Payable | 130.46 | 90.96 | 122.07 | 31.34 | -247.63 | 210.71 |
Change in Other Net Operating Assets | 22.3 | 82.63 | -115.21 | -138.13 | -168.11 | -58.15 |
Operating Cash Flow | 1,914 | 1,752 | 1,401 | 693.3 | 351.15 | 736.72 |
Operating Cash Flow Growth | 29.68% | 25.00% | 102.11% | 97.44% | -52.34% | -8.17% |
Capital Expenditures | -122.89 | -89.87 | -99.46 | -119.67 | -134.84 | -102.71 |
Cash Acquisitions | -139.1 | -139.25 | -133.46 | -1,013 | -42.78 | -39.07 |
Sale (Purchase) of Intangibles | -15.02 | -10.78 | -15.4 | -14.33 | -21.2 | -14.11 |
Investment in Securities | -9.97 | -1.79 | -11.77 | -28.29 | -13.92 | -21.79 |
Other Investing Activities | 17.95 | 41.63 | -9.7 | 15.2 | -17.18 | 19.22 |
Investing Cash Flow | -269.02 | -200.05 | -269.78 | -1,160 | -229.92 | -158.46 |
Long-Term Debt Issued | - | - | 105 | 1,070 | 288 | 90 |
Long-Term Debt Repaid | - | -40 | -835 | -405 | -166 | -612 |
Net Debt Issued (Repaid) | -10 | -40 | -730 | 665 | 122 | -522 |
Issuance of Common Stock | 76.94 | 74.44 | 53.09 | 49.14 | 47.38 | 37.79 |
Repurchase of Common Stock | -522.04 | -318.1 | -158.77 | -30.63 | -52.41 | -50.21 |
Common Dividends Paid | -330.63 | -310.88 | -282.32 | -258.28 | -245.34 | -226.71 |
Other Financing Activities | -10.86 | -11.71 | -1.29 | -2.36 | - | -3.5 |
Financing Cash Flow | -796.58 | -606.25 | -1,119 | 422.87 | -128.36 | -764.63 |
Foreign Exchange Rate Adjustments | 46.23 | 25.8 | -1.72 | -2.15 | -14.43 | 18.5 |
Net Cash Flow | 895.13 | 971.09 | 10.47 | -45.82 | -21.57 | -167.88 |
Free Cash Flow | 1,792 | 1,662 | 1,302 | 573.63 | 216.31 | 634.01 |
Free Cash Flow Growth | 28.73% | 27.65% | 126.94% | 165.19% | -65.88% | -10.32% |
Free Cash Flow Margin | 33.19% | 32.29% | 27.79% | 13.58% | 6.04% | 19.83% |
Free Cash Flow Per Share | 12.20 | 11.28 | 8.82 | 3.89 | 1.47 | 4.33 |
Cash Interest Paid | 34.6 | 28.42 | 45.71 | 47.38 | 22.31 | 23.99 |
Cash Income Tax Paid | 199.08 | 214.01 | 278.4 | 216.87 | 478.12 | 221.36 |
Levered Free Cash Flow | 1,417 | 1,208 | 1,185 | 400.59 | 127.68 | 779.72 |
Unlevered Free Cash Flow | 1,417 | 1,208 | 1,216 | 432.55 | 141.63 | 794.48 |
Change in Working Capital | 74 | 16.74 | 44.78 | -462.13 | -708.08 | 1.41 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.